Medical Condition News

RSS

Biothera begins dosing in Imprime PGG and cetuximab combination Phase III trial for colorectal cancer

Biothera began dosing patients today in a Phase III trial evaluating Imprime PGG in combination with cetuximab as a potential new treatment for recurrent or progressive KRAS wild-type colorectal cancer.

19 May 2011

Fragile X syndrome may be treatable

Advancements over the last 10 years in understanding intellectual disability (ID, formerly mental retardation), have led to the once-unimaginable possibility that ID may be treatable, a review of more than 100 studies on the topic has concluded. It appears in ACS Chemical Neuroscience.

18 May 2011

New image-processing software allows significant radiation dose reduction

A reduction by half in the radiation dose to which cardiac patients are exposed during diagnostic perfusion imaging is now "feasible", according to an Israeli study.

18 May 2011

InvoTek introduces new Safe Laser System for persons with limited movement

InvoTek, Inc., a research and development company in Alma, Arkansas, has launched a new product using safe laser technology that enables a person with limited movement to write, communicate, and control their environment. The product will be unveiled at the Abilities Expo 2011 in Newark, New Jersey on Friday, May 20, 2011.

18 May 2011

Early childhood food allergies increase risk of severe allergy-related conditions and asthma later in life

Early results from the largest cross-sectional national allergy study ever conducted, to be released later this month, demonstrate that food allergies commonly occur in infants and toddlers, while environmental allergies, such as to dust, ragweed and mold, are more common in older children and adults.

From Quest Diagnostics 18 May 2011

Scientists nail mechanism causing embryonic stem cells to differentiate into specialised cells

A team led by developmental biologist Professor Christophe Marcelle has nailed the mechanism that causes stem cells in the embryo to differentiate into specialised cells that form the skeletal muscles of animals' bodies.

18 May 2011

Synergy expands GC-C agonist technology to lower cholesterol

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has successfully completed preclinical in vitro research demonstrating the inhibition of bile acid uptake by GC-C agonists and that it plans to commence animal studies shortly. Synergy believes this is the first time that GC-C agonists have been shown to potentially lower cholesterol.

18 May 2011

Oak Point students raise $42,474.24 to combat cancer

Penny by penny, students at Oak Point Intermediate School in Eden Prairie, MN, raised an incredible $42,474.24 through Pennies for Patients, making them the top fundraiser nationwide in The Leukemia & Lymphoma Society's School & Youth Programs.

18 May 2011

Improved tissue grafts promote vascular growth in wound sites

Victims of third-degree burns and other traumatic injuries endure pain, disfigurement, invasive surgeries and a long time waiting for skin to grow back. Improved tissue grafts designed by Cornell scientists that promote vascular growth could hasten healing, encourage healthy skin to invade the wounded area and reduce the need for surgeries.

18 May 2011

Pharma Two B plans to initiate P2B001 Phase II study in Parkinson's disease

Pharma Two B announced today it is planning a Phase II study of its new combination therapy, P2B001, in development as a treatment for the early stages of Parkinson's disease. Assuming regulatory approval and the necessary financing, the company plans to commence the Phase II trial in Q4 2011.

18 May 2011

Gingrich focuses attention on aging research

The presidential hopeful urged more investment in Alzheimer's research as a step that would lead to savings down the road. Meanwhile, The AP reports how the tight budget could pit scientific priorities against each other in a funding competition.

18 May 2011

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

Genentech, a member of the Roche Group, today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin in ovarian cancer, will be presented at the 47th Annual Meeting of the American Society of Clinical Oncology.

18 May 2011

New insight into skin hardening syndromes

Researchers from Boston University School of Medicine have discovered new details about the underlying mechanisms of skin hardening syndromes.

18 May 2011

Clinical data of Medtronic's Resolute drug-eluting stent in diabetes presented at EuroPCR meeting

For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent from Medtronic, Inc., provided remarkably safe and effective outcomes, according to the results of several studies presented today at EuroPCR, a major international meeting for cardiac and vascular specialists.

From Medtronic 18 May 2011

New book provides insight into new stem cell therapies for stabilizing heart function

A new book edited by researchers at Worcester Polytechnic Institute and the Stony Brook University School of Medicine provides a comprehensive look at the science and application of cellular therapies aimed at the leading cause of death---heart disease.

18 May 2011

Restrictive gadolinium-based contrast agent guidelines help prevent nephrogenic systemic fibrosis

A simple blood test may help prevent a serious complication associated with a contrast agent commonly used in MRI exams, according to a study published in the July issue of Radiology.

18 May 2011

Study: 80% of U.S. physicians use Herceptin for HER2-positive metastatic gastric cancer treatment

In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.

18 May 2011

Workplace smoking ban improves respiratory health and reduces emergency admissions

Workplace smoking bans are gaining ground globally, and one study has shown that they may have significant health effects. The study, conducted by researchers in Dublin, found that emergency room admissions due to respiratory illness dropped significantly in Ireland after the implementation of a workplace smoking ban, compared to admissions that took place before the ban went into effect.

18 May 2011

New interactive website for patients with schizophrenia

Schizophrenia24x7.com is a new, interactive website featuring helpful resources, information and interactive tools for people affected by schizophrenia.

18 May 2011

JCO publishes Micromet's blinatumomab Phase 2 trial data in acute lymphoblastic leukemia

Micromet, Inc. today announced that data from a Phase 2 clinical trial of the Company's lead product candidate blinatumomab in patients with minimal residual disease positive acute lymphoblastic leukemia were published in the May 16th on-line edition of the Journal of Clinical Oncology.

18 May 2011

Medical Condition News

Biothera begins dosing in Imprime PGG and cetuximab combination Phase III trial for colorectal cancer

Fragile X syndrome may be treatable

New image-processing software allows significant radiation dose reduction

InvoTek introduces new Safe Laser System for persons with limited movement

Early childhood food allergies increase risk of severe allergy-related conditions and asthma later in life

Scientists nail mechanism causing embryonic stem cells to differentiate into specialised cells

Synergy expands GC-C agonist technology to lower cholesterol

Oak Point students raise $42,474.24 to combat cancer

Improved tissue grafts promote vascular growth in wound sites

Pharma Two B plans to initiate P2B001 Phase II study in Parkinson's disease

Gingrich focuses attention on aging research

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

New insight into skin hardening syndromes

Clinical data of Medtronic's Resolute drug-eluting stent in diabetes presented at EuroPCR meeting

New book provides insight into new stem cell therapies for stabilizing heart function

Restrictive gadolinium-based contrast agent guidelines help prevent nephrogenic systemic fibrosis

Study: 80% of U.S. physicians use Herceptin for HER2-positive metastatic gastric cancer treatment

Workplace smoking ban improves respiratory health and reduces emergency admissions

New interactive website for patients with schizophrenia

JCO publishes Micromet's blinatumomab Phase 2 trial data in acute lymphoblastic leukemia

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News